Since 2005 [1] , genome-wide association studies (GWAS) and Next Generation Sequencing (NGS) have opened up new realms of investigation into the association between different diseases/traits and a large number of genetic loci. To date, more than 1 200 GWAS on over 250 traits have been published [2] . The advent of NGS and affordable whole genome and exome sequencing has accelerated the discovery of the genes underlying Mendelian diseases and has also enhanced our ability to detect rare variants. These variants may explain the missing heritability of common diseases and specific traits [3] .
To discriminate the true trait/disease-associated SNPs (TASs) from the large number of loci discovered by GWAS and NGS studies, we need further downstream statistical and bioinformatics analyses [4] . Variant visualization, functional annotation and prioritization are vital for determining the true associations between genetic markers and diseases/traits, from the multiple signals many of which represent chance findings. In addition, an increasing number of requirements, such as clarity, diversity and interactivity, pose demands on data visualization [5, 6] . Thorough functional annotations based on genomic location and potential biological effects are needed, especially for markers with moderate effects located in regulatory regions (e.g., non-coding RNAs, enhancers and promoters, and those in evolutionarily conserved regions) [7] [8] [9] , and for markers that have functional interactions with other TASs [10] . Comprehensive variant annotation will undoubtedly accelerate this process. Existing bioinformatics tools such as ANNOVAR [11] and VAAST [12] use genomic mapping to produce variant annotation, but few tools focus on the potential functional effects of TASs. Importantly, to properly distinguish the true association of TASs from the huge amount of GWAS signals, particularly for hidden TASs with moderate P-value, an annotation-based prioritizing process is required. Therefore, tools that can visualize, annotate and prioritize such data are urgently needed.
We have developed the GWASrap tool (http://jjwanglab.org/gwasrap) that systematically supports genetic variant representation, annotation and prioritization for data generated from GWAS and NGS ( Figure 1 and Supplementary information, Data S1). Table S2 ). Researchers can also re-evaluate the significance of a TAS using the dynamic linkage disequilibrium (LD) panel (Supplementary information, Figure S8 ) or the tree-like network panel (Supplementary information, Figure S10 ). The GWASrap supports input variants in different formats, not only common variants with a dbSNP rs ID but also npg rare variants from NGS data, which are represented by chromosome and locations. We used a Circos-style [13] plot to represent all SNPs in the NHGRI GWAS Catalog (up to February 2012). Compared to the original graph and the traditional Manhattan plot, our plot provides a very broad horizontal area for sanity checking of the current status of GWAS data. For a given GWAS dataset for a specific disease/trait, researchers can easily locate the significant region by looking at the single chromosome plot or by interacting with the dynamic Manhattan panel. The surrounding features and glyphs contain sufficient genetic information to provide an intuitive overview of the GWAS results.
In the prioritization step, we first estimated the likelihood of disease associations for each type of SNP (missense, nonsence, synonymous, etc.) by mapping those data to the dataset of HapMap3. We then computed the variant's genomic mapping score and functional prediction score based on the variant's annotation information. The prioritization score was then computed from the product of above scores (Supplementary information, Data S1). We have tested our prioritization method on several different datasets and found it to be very reliable. We first applied our prioritization method to diseasecausal SNPs from the OMIM database, and found that the prioritization scores were significantly different between disease-causal SNPs and randomly sampled background SNPs (Supplementary information, Figures S11-S13). Next, we re-scored the top 100 SNPs from the GWAS Catalog taking into account the synthetic associations of the LD proxy. The resulting scores were closer to that of the benchmarked 100 OMIM SNPs compared with the original scores and random background (Supplementary information, Figure S14 ). Finally, by applying the prioritization method to a bipolar disorder (BPD) GWAS study, we successfully selected the variants with the strongest effect that were confirmed in a separate study (Supplementary information, Tables S3 and S4 ). For example, SNP rs1042779 in ITIH1 gene, with many deleterious attributes, obtained a progressively stronger signal after the prioritization step. The variant is highly associated with a non-synonymous variant rs11177 in GNL3 gene and a synonymous variant rs2251219 in PBRM1 gene, which had a very significant signal in a recent BPD GWAS (Supplementary information, Figure  S15 ). In addition, an intronic variant rs420259, which was indicated as a high-risk marker in another GWAS, scored considerably higher after applying our prioritization method.
We have built a local database designed around a user-friendly web interface and web services to provide a rapid diagnostic tool for genetic variants. Our system accepts a submission query as either a dbSNP ID or a chromosomal location, and will quickly return the annotation information displayed on an interactive LD panel (Supplementary information, Figure S9 ). In the case of a rare variant or de novo variant without a dbSNP ID, the user can use genomic coordinates to obtain sufficient annotation. Our database also hosts well-structured and upto-date repositories from all significant TASs found in popular diseases frequently investigated by GWAS. For each specific disease/trait, we have integrated significant SNPs for the disease/trait, which were annotated in the GWASdb database [14] .
In summary, our system offers a universal web portal for GWAS/NGS representation, annotation and prioritization. The system will benefit users for data visualization and facilitate the functional annotation of genetic variants discovered by GWAS and NGS studies.
